A Win For First Wave BioPharma Inc.
Tue, Sep 05, 2023 at 07:10 PM
First Wave BioPharma Inc. (FWBI:NASDAQ) soared at $0.45, representing a gain of 55.2%. On Tue, Sep 05, 2023, FWBI:NASDAQ hit a New 2-Week High of $0.45. The stock appeared on our News Catalysts scanner on Tue, Sep 05, 2023 at 09:17 AM in the 'MISCELLANEOUS' category. From Tue, Aug 22, 2023, the stock recorded 22.22% Up Days and 20.00% Green Days
The stock spiked on Tue, Sep 05, 2023 at $0.79 with a volume of 65M+.
About First Wave BioPharma Inc. (FWBI:NASDAQ)
First Wave BioPharma Inc is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases.
Top 10 Gainers:
- Verb Technology Company, Inc. (VERB:NASDAQ), 347.24%
- First Wave BioPharma Inc. (FWBI:NASDAQ), 55.17%
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 52.7%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 50%
- GD Culture Group Ltd Com (New) (GDC:NASDAQ), 48.01%
- Cellectar Biosciences, Inc. (CLRB:NASDAQ), 36.26%
- Akso Health Group (AHG:NASDAQ), 32.41%
- Avalon GloboCare Corp. (ALBT:NASDAQ), 31.67%
- Digital Brands Group Inc. (DBGI:NASDAQ), 31.56%
- Applied Molecular Transport Inc. (AMTI:NASDAQ), 30.18%